Order results by:
| Issue | Title | |
| Vol 15, No 3 (2019) | Study of the Association of V640L (rs6133) Polymorphism in the Platelet P-selectin Gene with Acetylsalicylic Acid Resistance in Patients after Coronary Bypass Surgery | Abstract similar documents |
| A. A. Kosinova, T. S. Mongush, M. D. Goncharov, T. N. Subbotina, K. S. Semashchenko, G. Y. Kochmareva, Yu. I. Grinshtein | ||
| "... Aim. To study the association of V640L (rs6133) polymorphism in the P-selectin gene ..." | ||
| Vol 4, No 3 (2008) | OMEGA-3 POLYUNSATURATED FATTY ACIDS IN ATRIAL FIBRILLATION PREVENTION AFTER SURGICAL MYOCARDIAL REVASCULARIZATION | Abstract similar documents |
| A. V. Panov, B. A. Tatarskiy, M. L. Gordeev, R. I. Nilk | ||
| "... groups were similar in clinical characteristics. ω-3 PUFA therapy started 7±4 day before CABG, renewed ..." | ||
| Vol 12, No 3 (2016) | CLINICAL AND LABORATORY CHARACTERISTICS OF PATIENTS WITH ISCHEMIC HEART DISEASE RESISTANT TO ACETYLSALICYLIC ACID IN PERIOPERATIVE PERIOD OF CORONARY ARTERY BYPASS GRAFT: RESULTS OF AN OPEN PROSPECTIVE STUDY | Abstract PDF (Eng) similar documents |
| Yu. I. Grinshtein, A. A. Kosinova, I. Yu. Grinshtein, A. V. Kovalev, V. G. Sukhovol'skiy, A. A. Savchenko | ||
| "... was studied one day before CABG and at the 1st and 10th days after CABG using an optical aggregometer ..." | ||
| Vol 17, No 1 (2021) | Aspirin Resistance as a Result of Impaired Interaction of Platelets and Neutrophils in Patients with Coronary Heart Disease | Abstract similar documents |
| M. D. Goncharov, A. A. Savchenko, Yu. I. Grinshtein, I. I. Gvozdev, A. A. Kosinova, T. S. Mongush | ||
| "... CABG. In the postoperative period, from the first day, all patients were received 100 mg of an enteric ..." | ||
| Vol 19, No 6 (2023) | Acute kidney injury as a risk factor for atrial fibrillation after coronary artery bypass grafting — effects of sodium-glucose cotransporter-2 inhibitors | Abstract similar documents |
| L. V. Kremneva, L. A. Arutyunyan, L. I. Gapon, S. N. Suplotov, S. V. Shalaev | ||
| "... after coronary artery bypass grafting (CABG), as well as to evaluate the effect of sodium-glucose ..." | ||
| Vol 8, No 5 (2012) | PRESENT DAY DOCTORS LACK BENEFICENCE AND EMPATHY | similar documents |
| N. V. Dolgushina | ||
| Vol 8, No 4 (2012) | UP TO DAY POSSIBILITIES OF ATRIAL FIBRILLATION PREVENTION | Abstract similar documents |
| E. A. Protasova, N. V. Furman, O. V. Reshet'ko | ||
| Vol 10, No 6 (2014) | DYNAMICS OF STRUCTURAL AND FUNCTIONAL STATUS OF MYOCARDIUM DUE TO COMBINATION THERAPY WITH AMLODIPINE AND BISOPROLOL IN PATIENTS WITH ARTERIAL HYPERTENSION | Abstract similar documents |
| I. L. Zapesochnaya, A. G. Avtandilov | ||
| "... patients who work only day shift; the second group – 68 patients who work alternate (day/night) shifts ..." | ||
| Vol 13, No 3 (2017) | ACUTE ATORVASTATIN RECAPTURE THERAPY IN CORONARY ARTERY BYPASS GRAFTING | Abstract similar documents |
| A. V. Panov, M. L. Gordeev, A. A. Zhloba, T. F. Subbotina, I. V. Suhova, M. I. Buthashvili, I. T. Abesadze, M. Z. Alugishvili, N. L. Lohovinina, K. V. Korzhenevskaya, M. V. Solovyova, L. V. Mihaylova, E. S. Alekseevskaya | ||
| "... to the maximum allowed with subsequent taking of 40 mg/day. Complications after CABG, indicators of lipid ..." | ||
| Vol 16, No 4 (2020) | Optimization of a Comprehensive Prehabilitation Program for Patients with Stable Coronary Artery Disease Undergoing Elective Coronary Artery Bypass Grafting | Abstract PDF (Eng) similar documents |
| Yu. A. Argunova, T. N. Zvereva, S. A. Pomeshkina, A. V. Ivanova, O. M. Polikutina, O. V. Gruzdeva, V. V. Kashtalap, O. L. Barbarash | ||
| "... the optimization of drug therapy for patients undergoing elective coronary artery bypass grafting (CABG). Material ..." | ||
| Vol 18, No 1 (2022) | Omega-3 Polyunsaturated Fatty Acids: the Role in Prevention of Atrial Fibrillation in Patients with Coronary Artery Disease after Coronary Artery Bypass Graft Surgery | Abstract PDF (Eng) similar documents |
| O. A. Rubanenko, Yu. V. Shchukin, L. V. Limareva, T. K. Ryazanova, A. O. Rubanenko, I. L. Davydkin | ||
| "... fibrillation (AF) prevention after planned coronary artery bypass graft (CABG) surgery. Material and Methods ..." | ||
| Vol 19, No 2 (2023) | Clinical Efficacy and Safety of Empagliflozin in Patients with Acute Heart Failure from the First Day of Hospitalization | Abstract similar documents |
| D. P. Golubovskaya, V. N. Karetnikova, A. B. Osokina, I. P. Oleinik, O. L. Barbarash | ||
| "... with acute decompensated heart failure (ADHF) from the first day of hospitalization in the absence of signs ..." | ||
| Vol 5, No 2 (2009) | THE STRUCTURE OF DRUG PRESCRIPTION IN ACUTE CORONARY SYNDROME WITHOUT ST SEGMENT ELEVATION ON THE FIRST DAY OF HOSPITAL THERAPY | Abstract PDF (Eng) similar documents |
| O. V. Reshetko, N. V. Furman, R. M. Magdeev | ||
| "... infarction and unstable angina) on the first day of hospital therapy in Saratov city and Saratov region ..." | ||
| Vol 7, No 2 (2011) | PHARMACOEPIDEMIOLOGICAL ANALYSIS OF THE TREATMENT OF PAROXYSMAL AND PERSISTENT ATRIAL FIBRILLATION IN EVERY DAY CLINICAL PRACTICE | Abstract similar documents |
| I. V. Graifer, O. V. Reshet'ko, N. V. Furman | ||
| Vol 4, No 5 (2008) | COMPARISON OF EFFICACY AND TOLERABILITY OF ORIGINAL AND GENERIC DRUGS OF SIMVASTATIN IN PATIENTS WITH HYPERLIPIDAEMIA AND HIGH RISK OF ISCHEMIC HEART DISEASE COMPLICATIONS | Abstract similar documents |
| S. N. Tolpygina, S. Y. Martsevich | ||
| "... . 30 patients (19 men and 11 women, 64,0±1,8 y.o.) with low density lipoprotein (LDL) cholesterol ≥3 ..." | ||
| Vol 4, No 3 (2008) | THE RUSSIAN DATA OF INTERNATIONAL ENDORSE REGISTER (EPIDEMIOLOGIC INTERNATIONAL DAY FOR THE EVALUATION OF PATIENTS AT RISK OF VENOUS THROMBOSIS IN ACUTE HOSPITAL CARE SETTING) | Abstract similar documents |
| V. A. Sulimov, S. M. Belentsov, N. I. Golovina, N. P. Dubrovnaja, K. P. Zhidkov, K. V. Yeliseyeva, P. O. Kazanchan, A. V. Redkin, G. V. Rodoman, I. L. Fridman, V. N. Shershnev | ||
| "... and methods. ENDORSE (Epidemiologic International Day for the Evaluation of Patients at Risk of Venous ..." | ||
| Vol 18, No 2 (2022) | The Influence of Multivessel Bypass Surgery on the Onset of Atrial Fibrillation in Elderly Patients | Abstract similar documents |
| O. A. Rubanenko, A. O. Rubanenko | ||
| "... disease. Methods. The study included 454 patients with coronary artery disease who underwent CABG ..." | ||
| Vol 9, No 5 (2013) | THE ROLE OF LIPOTROPIC THERAPY IN PATIENTS WITH CHRONIC ISCHEMIC HEART DISEASE BEFORE AND AFTER CORONARY REVASCULARIZATION | Abstract similar documents |
| R. N. Adzhiev, M. S. Safarova, M. V. Ezhov | ||
| "... , Post-CABG, TNT) and meta-analyzes on the role of statins, prescribed before and after coronary artery ..." | ||
| Vol 18, No 6 (2022) | Predictors of Long-Term Outcomes after Surgical Myocardial Revascularization | Abstract similar documents |
| V. S. Kaveshnikov, M. A. Kuzmichkina, V. N. Serebryakova | ||
| "... and postoperative factors on the long-term prognosis after coronary artery bypass grafting (CABG). The review refers ..." | ||
| Vol 14, No 5 (2018) | Impact of Pre-Diabetes on the Rate of Major Adverse Cardiovascular Events in Patients Undergoing Coronary Artery Bypass Grafting | Abstract similar documents |
| A. N. Sumin, N. A. Bezdenezhnykh, A. V. Bezdenezhnykh, S. V. Ivanov, O. L. Barbarash | ||
| "... artery bypass grafting (CABG). Material and methods. 347 CAD patients who underwent CABG in the period ..." | ||
| Vol 16, No 5 (2020) | The Role of Adherence to Basic Pharmacotherapy of Heart Failure for Prevention of Late Adverse Events in Patients with Coronary Artery Disease and Left Ventricular Dysfunction After Surgical Revascularization of Myocardium | Abstract PDF (Eng) similar documents |
| O. A. Yepanchintseva, K. A. Mikhaliev, I. V. Shklianka, O. J. Zharinov, B. M. Todurov | ||
| "... ) in prevention of late major adverse events (MAEs) after isolated coronary artery bypass grafting (CABG ..." | ||
| Vol 18, No 3 (2022) | Study the Association of Nucleotide Polymorphisms in Platelet Receptor and Cytochrome P450 Genes with the Development of Resistance to Antiplatelet Drugs in Patients with Coronary Artery Disease | Abstract similar documents |
| K. S. Semashchenko, T. S. Mongush, A. A. Kosinova, T. N. Subbotina, Y. I. Grinshtein | ||
| "... . The study included 243 patients diagnosed with CHD after coronary artery bypass surgery (CABG), including ..." | ||
| Vol 11, No 5 (2015) | Efficacy of atorvastatin therapy in prevention of postoperative atrial fibrillation in patients with ischemic heart disease | Abstract similar documents |
| O. A. Rubanenko | ||
| "... ) development after coronary artery bypass graft (CABG) surgery in patients with ischemic heart disease (IHD ..." | ||
| Vol 16, No 1 (2020) | An Attempt to Accord the Quality of Therapy of Stable Coronary Heart Disease Patients with Current Clinical Guidelines (ALIGN study): Design and the First Results | Abstract similar documents |
| S. Yu. Martsevich, E. D. Zharkova, N. P. Kutishenko, Yu. V. Lukina, S. N. Tolpygina, V. P. Voronina, A. V. Zagrebelnyy | ||
| "... ). Arterial hypertension was registered in 90.1% of patients, stable angina class I-III – in 62%, 47.9 ..." | ||
| Vol 19, No 2 (2023) | Prognosis of Adverse Outcomes in the Research of Coronary Blood Flow During Echocardiography | Abstract similar documents |
| E. S. Kalinina, A. V. Zagatina, S. A. Sayganov | ||
| "... infarction (MI), death/ MI, myocardial revascularization operations - stenting and aortocoronary bypass (CABG ..." | ||
| Vol 12, No 4 (2016) | Comparative Analysis of All-cause and Cardiovascular Mortality in Moscow and Irkutsk | Abstract PDF (Eng) similar documents |
| F. I. Belyalov, I. V. Samorodskaya, S. V. Pogodaeva | ||
| "... forms of ischemic heart disease (47.9% in Irkutsk and 45.9% in Moscow) and cerebrovascular diseases (15 ..." | ||
| Vol 11, No 2 (2015) | COMPARATIVE EVALUATION OF HEMODYNAMIC CHARACTERISTICS IN PATIENTS WITH RHEUMATOID ARTHRITIS AND ARTERIAL HYPERTENSION | Abstract similar documents |
| Y. E. Teregulov, D. K. Husainova, D. I. Abdulganeeva, S. D. Mayanskaya | ||
| "... (22 (35%) women and 41 (65%) men, mean age 47.9±12.8 years) with HT stages 1-3. The control group ..." | ||
| Vol 18, No 2 (2022) | Leading Factors of Progression in Patients with Cardiac Amyloidosis | Abstract similar documents |
| A. S. Rameeva, V. V. Rameev, I. N. Bobkova, A. F. Safarova, Zh. D. Kobalava, S. V. Moiseev | ||
| "... shortening strain rate (48,5%) decreased filtration rate (47,9%) was second of main factors contributing ..." | ||
| Vol 14, No 2 (2018) | SINGLE AND MULTIPLE ISCHEMIC BRAIN MICROLESIONS AFTER CAROTID ARTERY STENTING | Abstract similar documents |
| E. S. Bulgakova, T. V. Tvorogova, В. A. Rudenko, O. М. Drapkina | ||
| "... with multiple microlesions (n=25) differed from patients without lesions (n=45) older age (67.0 [64.0; 77.0] vs ..." | ||
| Vol 7, No 6 (2011) | EFFICACY OF CORONARY STENTING AND BASIC PHARMACOTHERAPY IN ELDERLY AND SENILE PATIENTS: THE RESULTS OF LONG-TERM PROSPECTIVE FOLLOW-UP | Abstract similar documents |
| L. R. Mirzakhanova | ||
| "... in patients with pharmacotherapy only (from 48.3±6.40% to 49.1±5.86%). Conclusion. Coronary stenting ..." | ||
| Vol 15, No 5 (2019) | Association Between Lipoprotein(a) and Risk Factors of Atherosclerosis in Russian Population (Data of Observational ESSE-RF study) | Abstract PDF (Eng) similar documents |
| S. A. Shalnova, M. V. Ezhov, V. A. Metelskaya, S. E. Evstifeeva, V. I. Tarasov, G. A. Muromtseva, Yu. A. Balanova, A. E. Imaeva, A. V. Kapustina, A. A. Shabunova, O. A. Belova, I. A. Trubacheva, A. Y. Efanov, Z. T. Astakhova, N. V. Kulakova, S. A. Boytsov, O. M. Drapkina | ||
| "... , of whom 3732 were men (36.0%) and 6600 were women (64.0%), the average age was equal in both sexes ..." | ||
| Vol 17, No 6 (2021) | PCSK9 Inhibitors in Clinical Practice: Experience of a Specialized Lipid Center | Abstract similar documents |
| A. V. Blokhina, A. I. Ershova, A. S. Limonova, O. V. Kopylova, A. N. Meshkov, O. M. Drapkina | ||
| "... ] years), the majority (64.0%) had a probable or definite familial hypercholesterolemia (FH ..." | ||
| Vol 13, No 2 (2017) | FACTORS INFLUENCING THE FORMATION OF BURNOUT SYNDROME IN PATIENTS WITH WORKPLACE HYPERTENSION | Abstract similar documents |
| Yu. P. Zinchenko, E. I. Pervichko, O. D. Ostroumova | ||
| "... ] as well as one of the most mature protective processes (intellectualization - 53% and 47.9%, respectively ..." | ||
| Vol 15, No 3 (2019) | The First Results of the Evaluation of Long-Term Nicorandil Treatment Effect on the Probability of Cardiovascular Complications in Patients with Stable Coronary Artery Disease (Data of Observational NIKEA Study) | Abstract similar documents |
| S. Yu. Martsevich, Yu. V. Lukina, N. P. Kutishenko, V. P. Voronina, N. A. Dmitrieva, A. V. Zagrebelnyy, O. V. Lerman, O. V. Gaisenok, T. A. Gomova, A. V. Ezhov, A. D. Kuimov, R. A. Libis, G. V. Matyushin, T. N. Mitroshina, G. I. Nechaeva, I. I. Reznik, V. V. Skibitsky, A. I. Chesnikova, N. V. Dobrynina, S. S. Yakushin | ||
| "... of CAD, chronic heart failure (CHF) or atrial fibrillation (AF). In 479 patients, a telephone survey ..." | ||
| Vol 14, No 4 (2018) | Hospital Stage of Myocardial Infarction Treatment in 13 Regions of Russian Federation by Results of the International Research | Abstract PDF (Eng) similar documents |
| A. V. Kontsevaya, K. Bates, E. A. Goryachkin, N. Bobrova, L. I. Syromiatnikova, Yu. V. Popova, D. Yu. Platonov, I. V. Osipova, A. M. Nedbaikin, T. N. Malorodova, O. A. Mirolyubova, D. V. Kryuchkov, L. A. Khaisheva, A. S. Galyavich, M. V. Franz, A. Yu. Efanov, D. V. Duplyakov, O. M. Drapkina, D. Leon, M. McKee | ||
| "... PCI, and 2.2% CABG. Turning to cardiovascular risk factors, 46.2% of patients smoked prior ..." | ||
| Vol 17, No 1 (2021) | Using the ORACLE Risk Score to Assess Hemorrhagic Risk in Patients with Acute Coronary Syndrome and Atrial Fibrillation | Abstract PDF (Eng) similar documents |
| V. A. Brazhnik, L. O. Minushkina, A. D. Erlikh, E. D. Kosmacheva, M. A. Chichkova, N. R. Khasanov, D. A. Zateyshchikov | ||
| "... .9±11.3 years and 64.0±12.2 years, p<0.001). Among these patients there was a larger proportion of women ..." | ||
| Vol 12, No 6 (2016) | CONCOMITANT CARDIOVASCULAR DISEASES AND ANTIHYPERTENSIVE TREATMENT IN OUTPATIENT PRACTICE (BY THE RECVASA REGISTRY DATA) | Abstract similar documents |
| M. Loukianov | ||
| "... and relative contraindications for betablockers use – in 64.0%. 15.2% of the hypertensive patients used ..." | ||
| Vol 12, No 1 (2016) | CONCOMITANT CARDIOVASCULAR DISEASES AND ANTIHYPERTENSIVE TREATMENT IN OUTPATIENT PRACTICE (BY THE RECVASA REGISTRY DATA) | Abstract PDF (Eng) similar documents |
| M. M. Loukianov, S. A. Boytsov, S. S. Yakushin, S. Yu. Martsevich, A. N. Vorobyev, A. V. Zagrebelnyy, N. N. Nikulina, K. G. Pereverzeva, E. A. Pravkina, A. D. Deev, E. V. Kudryashov, E. N. Belova | ||
| "... and relative contraindications for betablockers use – in 64.0%. 15.2% of the hypertensive patients used ..." | ||
| Vol 21, No 1 (2025) | Cytokine profile of surgical patients with infective endocarditis | Abstract similar documents |
| E. O. Kotova, A. S. Pisaryuk, A. V. Lokhonina, A. Y. Moiseeva, E. A. Domonova, T. A. Gusarova, J. I. Babukhina, P. V. Kakhktsyan, T. K. Fatkhudinov, Z. D. Kobalava | ||
| "... defects (n = 10, 40.0 %) and left-sided localization of IE (n = 16, 64.0 %). IHC revealed a predominance ..." | ||
| Vol 10, No 4 (2014) | EXPERIENCE IN THE USE OF BISOPROLOL IN THE TREATMENT OF OUTPATIENT HYPERTENSIVE PATIENTS AFTER STROKE | Abstract similar documents |
| I. I. Esenova, L. N. Lisenker | ||
| "... /day. Material and methods. Patients (n=12) with HT stage III with stroke history were examined. Age ..." | ||
| Vol 13, No 2 (2017) | PATIENTS WITH COMBINATION OF CHRONIC HEART FAILURE, HYPERTENSION AND HISTORY OF MYOCARDIAL INFARCTION: CLINICAL AND ANAMNESTIC CHARACTERISTICS, ADMINISTRATION OF ACE INHIBITORS, ANGIOTENSIN RECEPTOR BLOCKERS, -BLOCKERS AND ADHERENCE TO THE DRUG THERAPY (DATA OF OUTPATIENT REGISTRY RECVASA) | Abstract similar documents |
| M. M. Loukianov, A. N. Kozminsky, S. Yu. Martsevich, S. S. Yakushin, A. N. Vorobyev, A. V. Zagrebelnyy, R. P. Myasnikov, K. G. Pereverzeva, E. A. Pravkina, E. Yu. Andreenko, E. N. Belova, A. D. Deev, V. G. Klyashtorny, E. V. Kudryashov, S. A. Boytsov | ||
| "... CHF class 3-4 NYHA (62% vs 47.9%, respectively), HT of degree 3 (92.5% vs 84.2%, respectively), stable ..." | ||
| Vol 18, No 2 (2022) | Sequelae of COVID-19 at long-term follow-up after hospitalization | Abstract PDF (Eng) similar documents |
| N. V. Pogosova, F. N. Paleev, A. K. Ausheva, D. T. Kuchiev, S. A. Gaman, T. N. Veselova, M. B. Belkind, O. Yu. Sokolova, R. A. Zhetisheva, S. K. Ternovoy, S. A. Boytsov | ||
| "... years [49.0; 64.0]; men, 55.4%) agreed come for an outpatient visit and to participate in the “COVID-19 ..." | ||
| Vol 21, No 2 (2025) | Prognostic factors for stent restenosis in patients with coronary artery disease undergoing percutaneous coronary intervention | Abstract similar documents |
| M. А. Meshkova, I. A. Starodubtseva, A. A. Pashkova | ||
| "... and methods. The prospective study included 92 patients (mean age 64.0 years, 79.5% male, 20.5% female ..." | ||
| Vol 4, No 3 (2008) | ANXIETY AND DEPRESSION IN INTERNAL MEDICINE | Abstract similar documents |
| A. V. Fedotova | ||
| "... of these disorders in general practitioner every day practice is surveyed. Possibilities of anxiety and depression ..." | ||
| Vol 13, No 5 (2017) | INFLUENCE OF SWITCHING OF CLOPIDOGREL TO TICAGRELOR ON THE DEVELOPMENT OF CARDIOVASCULAR EVENTS IN PATIENTS WITH ST SEGMENT ELEVATION | Abstract similar documents |
| E. V. Tavlueva, A. V. Alekseenko, O. V. Gruzdeva, O. L. Barbarash | ||
| "... (100 mg/day) and clopidogrel 75 mg/day. Patients of the second group received maintenance doses ..." | ||
| Vol 12, No 1 (2016) | Interaction of rivaroxaban with amiodarone, verapamil and diltiazem in patients with atrial fibrillation: terra incognita | Abstract similar documents |
| S. N. Bel'diev | ||
| "... with these drugs: to 15 mg/day in patients with ClCr 50-79 ml/min and to 10 mg/day in patients with ClCr<50 ml/min. ..." | ||
| Vol 16, No 2 (2020) | The Effect of Pharmacological Preconditioning with Nicorandil before Elective Coronary Stenting on the Long-Term Prognosis of Patients with Stable Coronary Artery Disease | Abstract similar documents |
| G. N. Soboleva, R. V. Gostishchev, A. N. Rogoza, T. I. Kotkina, A. N. Samko, Yu. A. Karpov | ||
| "... with a standard medical treatment (n=92). Nicorandil was prescribed orally: 2 days before PCI – 30 mg/day ..." | ||
| Vol 19, No 3 (2023) | Association of polymorphic variants of CYP2C19, P2RY12, ITGB3, ITGA2 and eNOS3 genes with high residual platelet reactivity while taking clopidogrel and acetylsalicylic acid at different terms of myocardial infarction | Abstract similar documents |
| T. P. Pronko, V. A. Snezhitskiy, T. L. Stepuro, A. V. Kapytski | ||
| "... performed on days 1-2, 12-14 and 28-30 of MI, and genotyping by the polymerase chain reaction were analyzed ..." | ||
| Vol 13, No 3 (2017) | EFFECT OF SACUBITRIL/VALSARTAN ON NATRIURESIS, DIURESIS AND BLOOD PRESSURE IN HYPERTENSIVE PATIENTS | Abstract similar documents |
| Zh. D. Kobalava, S. V. Villevalde, I. A. Meray, O. I. Lukina | ||
| "... . Hypertensive patients (n=16) received sacubitril/valsartan 400 mg QD or valsartan 320 mg QD for 7 days ..." | ||
| Vol 7, No 4 (2011) | VALUE OF THERAPEUTIC EQUIVALENCE IN SUBSTITUTION OF ORIGINAL DRUG WITH GENERIC BY EXAMPLE OF FOSINIPRIL | Abstract similar documents |
| N. P. Kutishenko, S. Yu. Martsevich, Zh. D. Kobalava, E. K. Shavarova | ||
| "... was determined by randomization. Wash-out period (10-14 days) preceded each course. Treatment duration was 6 ..." | ||
| Vol 7, No 1 (2011) | ANTIARRHYTHMIC EFFICACY OF PROPAFENONE IN PATIENTS WITH PERSISTENT ATRIAL FIBRILLATION | Abstract similar documents |
| R. D. Kurbanov, N. U. Zakirov, Sh. K. Azizov | ||
| "... 53,8±13,3) with PAF (duration is more than 7 days) were included in the study. PAF was confirmed ..." | ||
| Vol 8, No 3 (2012) | EFFECT OF THE COMBINED ANTIHYPERTENSIVE THERAPY WITH TARGET BLOOD PRESSURE ACHIEVEMENT ON INTRARENAL BLOOD FLOW IN PATIENTS WITH TYPE 2 DIABETES | Abstract similar documents |
| O. A. Koshel'skaya, O. A. Zhuravleva | ||
| "... therapy with valsartan (n=20), 80–160 mg/day , or perindopril (n=21), 5–10 mg/day , in combination ..." | ||
| Vol 19, No 6 (2023) | Endovenous laser ablation of great saphenous vein and pharmacotherapy of acute ascending thrombophlebitis: results of a three-month follow-up | Abstract similar documents |
| K. A. Kaperiz, A. O. Rastatueva, I. S. Yavelov, O. M. Drapkina | ||
| "... with short-term (7-day) anticoagulant therapy or without anticoagulation. Material and methods. This single ..." | ||
| Vol 12, No 2 (2016) | LIPID-LOWERING THERAPY IN OUTPATIENT PRACTICE (ACCORDING TO THE ARGO-2 STUDY) | Abstract similar documents |
| N. M. Akhmedzhanov, D. V. Nebieridze, A. S. Safaryan, V. A. Vygodin, A. Yu. Shuraev, A. N. Tkacheva, A. S. Lishuta | ||
| "... was performed in 7897 patients in an average after 33 days. Baseline TC level in them was 6.37±0.89 mmol/l ..." | ||
| Vol 10, No 5 (2014) | EFFICACY OF ROSUVASTATIN IN DYSLIPIDEMIA CORRECTION IN PATIENTS AFTER Q-WAVE MYOCARDIAL INFARCTION | Abstract similar documents |
| R. D. Kurbanov, N. U. Zakirov, Y. G. Kevorkova, N. B. Sayfiddinova | ||
| "... into the study after 10-14 days of the acute Q-MI onset. Determination of blood lipids profile, alanine ..." | ||
| Vol 5, No 5 (2009) | EFFECTS OF ACETYLSALICYLIC ACID AND CLOPIDOGREL ON MORPHOFUNCTIONAL STATUS OF ERYTHROCYTES IN PATIENTS WITH ACUTE CORONARY SYNDROME | Abstract similar documents |
| A. L. Alyavi, R. A. Rakhimov, B. A. Alyavi | ||
| "... at baseline, after 3 and 7 days of treatment. Results. The highest efficacy of antiaggregant therapy ..." | ||
| Vol 13, No 2 (2017) | SECONDARY PREVENTION IN PATIENTS AFTER MYOCARDIAL INFARCTION AT AMBULATORY SPECIALIZED CARDIOLOGY INSTITUTION (PHARMACOEPIDEMIOLOGY STUDY) | Abstract similar documents |
| S. B. Fitilev, I. I. Shkrebneva, A. V. Vozzhaev, D. A. Dimitrova | ||
| "... prescriptions was revealed (at the second stage of the study acetylsalicylic acid 100 mg/day received 75 ..." | ||
| Vol 3, No 2 (2007) | NEBIVOLOL IN TREATMENT OF STABLE EXERTIONAL ANGINA PECTORIS | Abstract similar documents |
| Y. V. Gavrilov, V. A. Sulimov, V. I. Makolkin | ||
| "... exertional angina pectoris and having no contraindications to beta-blockers were studied. After 5-7 days ..." | ||
| Vol 4, No 5 (2008) | TREATMENT OF COGNITIVE DISORDERS IN HYPERTENSIVE PATIENTS EXPOSED TO RADIATION | Abstract similar documents |
| I. V. Podsonnaja, G. G. Efremushkin, V. A. Golovin | ||
| "... disorders were included in the study. Cortexin was used (10 mg intramusculary during 10 days) for one or two ..." | ||
| Vol 4, No 5 (2008) | AMLODIPINE ADVANTAGES IN ARTERIAL HYPERTENSION THERAPY | Abstract similar documents |
| V. M. Tsareva, N. J. Hozjainova, M. S. Bezaltynnyh, T. V. Brook, N. A. Borohova, I. E. Koltunov, N. M. Ahmedzhanov | ||
| "... (5-10 mg/day) therapy was started. ABPM, 24 hour electrocardiogram monitoring, echocardiography ..." | ||
| Vol 19, No 3 (2023) | Ventricular tachycardia and myocardial infarction during antiarrhythmic therapy: a case report | Abstract similar documents |
| A. A. Gurbanova, K. G. Pereverzeva, S. S. Yakushin, I. V. Budanova | ||
| "... therapy with diethylamino propionylethoxycarbonylaminophenothiazine 150 mg per day and sotalol 160 mg per ..." | ||
| Vol 12, No 5 (2016) | Features of the Hemostasis and Platelets Enzyme Activity in Patients with Different Sensitivity to Acetylsalicylic Acid by the Acute Coronary Syndrome | Abstract similar documents |
| I. Yu. Grinshtein, A. A. Savchenko, Yu. I. Grinshtein, M. M. Petrova | ||
| "... 10 days. The control group included 50 healthy volunteers. Before treatment the patients were tested ..." | ||
| Vol 7, No 3 (2011) | COMPARATIVE EVALUATION OF THE ANTIHYPERTENSIVE EFFECT OF PERINDOPRIL AND LOSARTAN POTASSIUM IN PATIENTS WITH ARTERIAL HYPERTENSION AND STENOTIC CORONARY ATHEROSCLEROSIS BEFORE REVASCULARIZATION: AN OPEN RANDOMIZED COMPARATIVE STUDY | Abstract similar documents |
| O. A. Osipova, N. N. Kurbakov, A. G. Ovsyannikov, M. A. Vlasenko | ||
| "... perindopril or losartan potassium. Perindopril was administered at dose of 4 mg/day with subsequent rising up ..." | ||
| Vol 13, No 6 (2017) | SUBFRACTION DISTRIBUTION OF APO B-CONTAINING LIPOPROTEINS DEPENDING ON THE ACHIEVEMENT OF THE TARGET LEVEL OF LOW DENSITY LIPOPROTEINS UNDER STATINS THERAPY IN PATIENTS WITH CORONARY ATHEROSCLEROSIS | Abstract similar documents |
| I. N. Ozerova, V. A. Metelskaya, N. E. Gavrilova | ||
| "... before admission: atorvastatin (10-40 mg/day), simvastatin (20-40 mg/day), rosuvastatin (10-40 mg/day ..." | ||
| Vol 4, No 2 (2008) | THE CHOICE OF NITRATE THERAPY IN PATIENTS WITH STABLE ANGINA: COMPARATIVE STUDY OF ISOSORBIDE DINITRATE (IN USUAL TABLETS) WITH ISOSORBIDE-5-MONONITRATE (IN VARIOUS PRESENTATIONS) | Abstract similar documents |
| V. A. Egoro, E. V. Shilova, S. Y. Martsevich | ||
| "... times a day administration; IMN (Monocinque,Berlin-Chemie, German) in tablets 20 mg prescribed for 2 ..." | ||
| Vol 17, No 5 (2021) | Efficiency of the Left Atrial Appendage Thrombus Dissolution in Patients with Persistent Nonvalvular Atrial Fibrillation with Warfarin or Direct Oral Anticoagulants Therapy | Abstract PDF (Eng) similar documents |
| E. S. Mazur, V. V. Mazur, N. D. Bazhenov, Yu. A. Orlov | ||
| "... at the level of 2-3, 14 (20.6%) started or continued taking dabigatran at a dose of 150 mg 2 times/day, 14 (20 ..." | ||
| Vol 17, No 5 (2021) | Pharmacogenetic Aspects of Postoperative Anesthesia with Ketoprofen in Cardiac Surgery Patients | Abstract similar documents |
| T. E. Morozova, D. A. Shatsky, N. V. Shikh, E. V. Shikh, T. B. Andrushchyshina, M. V. Lukina, A. A. Kachanova, Z. A. Sozaeva, G. N. Shuev, N. P. Denisenko, E. А. Grishina, D. A. Sychev | ||
| "... intramuscularly 2 times a day for 5 days. The intensity of pain was rated by Numeric Rating Scale. The severity ..." | ||
| Vol 21, No 2 (2025) | A randomized controlled trial of statin therapy effect on androgen status and erectile function in men with high and very high cardiovascular risk (TRISTAN): rationale and study protocol | Abstract similar documents |
| K. P. Raevskii, O. Yu. Nesterova, A. A. Strigunov, M. E. Chaliy, A. V. Kadrev, A. G. Plisyuk, A. A. Kamalov, Ya. A. Orlova | ||
| "... pitavastatin at a starting dose of 1 mg/day. Group 2 (n=75) will receive rosuvastatin 20 mg/day. After 3 months ..." | ||
| Vol 19, No 1 (2023) | Effect of Antibiotic Therapy on the Sensitivity of Etiological Diagnostic Methods in Patients with Infective Endocarditis after Surgery | Abstract similar documents |
| E. O. Kotova, A. Yu. Moiseeva, Zh. D. Kobalava, E. A. Domonova, A. S. Pisaruk, O. Yu. Silveistrova, P. V. Kakhktsyan, V. V. Vladimirov | ||
| "... sequencing. The duration of preoperative treatment was calculated from the first day of AMT according ..." | ||
| Vol 11, No 1 (2015) | ATRIAL FIBRILLATION ASSOCIATED WITH MYOCARDIAL INFARCTION OF DIFFERENT LOCALIZATIONS | Abstract similar documents |
| R. Bhattarai, S. A. Sayganov, E. V. Trofimova | ||
| "... evaluated. Results. In patients with anterior MI AF developed later than in those with inferior MI (on day ..." | ||
| Vol 8, No 4 (2012) | INHALED NITRIC OXIDE: CLINICAL EFFECTS AND INFLUENCE ON THE PROFILE OF INFLAMMATORY MARKERS IN PATIENTS WITH IDIOPATHIC PULMONARY HYPERTENSION | Abstract similar documents |
| T. V. Martynyuk, S. N. Nakonechnikov, V. P. Masenko, I. E. Chazova | ||
| "... a), soluble adhesion molecules (sICAM-1, sVCAM-1) in peripheral blood] were performed at baseline and on day ..." | ||
| Vol 8, No 5 (2012) | EFFICACY OF COMBINED ANTIHYPERTENSIVE THERAPY IN ACHIEVEMENT OF TARGET BLOOD PRESSURE IN DIABETIC PATIENTS | Abstract similar documents |
| O. A. Koshel'skaya, O. A. Zhuravleva, R. S. Karpov | ||
| "... to moderate DM type 2 were included into the study. The patients were treated with perindopril (5–10 mg/day ..." | ||
| Vol 14, No 2 (2018) | HYPERTENSION AND DIABETES MELLITUS TYPE 2 | Abstract similar documents |
| M. E. Statsenko, M. V. Derevyanchenko | ||
| "... ", combined therapy with amlodipine 6.2Ѓ}2.5 mg/day and lisinopril 12.3Ѓ}5.0 mg/day was prescribed ..." | ||
| Vol 20, No 5 (2024) | Early intravenous beta-blockers injection in patients with acute STEMI: the results of the Russian registry REGION-IM | Abstract similar documents |
| T. S. Sukhinina, M. A. Terenicheva, R. G. Gulyan, R. M. Shakhnovich, O. V. Stukalova, O. A. Saygina, I. S. Yavelov, D. V. Pevsner | ||
| "... (STEMI), information on the appointment or refusal of IV therapy on the first day of hospitalization ..." | ||
| Vol 5, No 4 (2009) | PREVENTION OF LEFT VENTRICLE SYSTOLIC DYSFUNCTION IN PATIENTS WITH ACUTE CORONARY SYNDROME WITH ST SEGMENT ELEVATION AFTER CARDIAC REVASCULARIZATION | Abstract similar documents |
| A. L. Alyavi, B. A. Alyavi, M. L. Kenzhaev, S. R. Kenzhaev | ||
| "... and stress-echocardiography with dobutamine after status stabilization (at 8-10 days of disease) were ..." | ||
| Vol 7, No 4 (2011) | USE OF ROSUVASTATIN AS A GEROPROTECTOR IN PEOPLE ENGAGED IN NATURAL GAS PRODUCING | Abstract similar documents |
| A. T. Abdrashitova, T. N. Panova, I. A. Belolapenko, M. V. Frenkel | ||
| "... . Rosuvastatin therapy in dose of 5 mg/day resulted in the reduction in atherogenic lipids, pro-inflammatory ..." | ||
| Vol 7, No 6 (2011) | CORONARY EMBOLISM WITH FRAGMENTED THROMBUS FROM THE LEFT VENTRICLE IN PATIENT WITH POSTINFARCTION ANEURYSM | Abstract similar documents |
| Yu. F. Salakhova, S. V. Gar'kina, T. V. Kislukhin, D. V. Duplyakov, V. S. Ivanov, E. R. Perunova, E. I. Bazhenova, S. E. Burnazyan, S. M. Khokhlunov | ||
| "... therapy (acetylsalicylic acid, clopidogrel, warfarin) was made on the 4th day of disease onset taking ..." | ||
| Vol 12, No 5 (2016) | Correction of Endothelial Dysfunction in Patients with Essential Hypertension when Using a Combination of Olmesartan/Lercanidipine and Zofenopril/Lercanidipine | Abstract similar documents |
| O. V. Zimnitskaya, M. M. Petrova | ||
| "... 1A, n=6) received a combination of olmesartan 10- 40 mg/day + lercanidipine 5-10 mg/day; another ..." | ||
| Vol 11, No 2 (2015) | THE EFFECTIVENESS OF LERCANIDIPINE IN REDUCING THE RISK OF ARTERIAL HYPERTENSION COMPLICATIONS | Abstract similar documents |
| E. EL. Trisvetova | ||
| "... or angiotensin II blockers the good antihypertensive effect with stable BP profile throughout the day ..." | ||
| Vol 16, No 3 (2020) | A Prospective, Initiative, Single-Center Open Post-Registration Comparative Study of Laboratory Efficacy of Various Forms of Acetylsalicylic Acid in a Cardioprotective Dose with Different Composition of Excipients: Results of the SFAIROS Study | Abstract similar documents |
| N. V. Lomakin, L. I. Buryachkovskaya, D. A. Zolin, V. I. Kazey | ||
| "... .002). The platelet aggregation after 3 days decreased and in groups 1, 2 and 3 were respectively 7.6%, 32.2% (p=0 ..." | ||
| Vol 19, No 1 (2023) | Analysis of The Use of PCSK9 Inhibitors in Clinical Practice | Abstract similar documents |
| S. Yu. Volkova, L. A. Boyarskaya, P. Yu. Toropygin, I. A. Morozov, E. A. Boyarskaya | ||
| "... every 2 weeks in the day hospital of a multidisciplinary clinic. The primary endpoint was reached ..." | ||
| Vol 13, No 1 (2017) | COMPARISON OF EFFECTIVENESS OF ANTIARRHYTHMIC THERAPIES IN POSTOPERATIVE PERIOD OF PULMONARY VEIN OSTIA CATHETER ISOLATION FOR PREVENTION OF EARLY RECURRENCES OF ATRIAL TACHYARRHYTHMIAS IN THE PROOF STUDY | Abstract similar documents |
| A. V. Tarasov, K. V. Davtyan, S. Yu. Martsevich | ||
| "... with a control. They were divided into 4 groups: Patients of Group 1 (n=61) received verapamil retard 240 mg/day ..." | ||
| Vol 7, No 1 (2011) | THE CHOICE OF THE DRUG AMLODIPINE FOR THE HYPERTENSION TREATMENT FROM THE STANDPOINT OF ECONOMIC FEASIBILITY | Abstract similar documents |
| S. Yu. Martsevich, N. A. Dmitrieva, A. D. Deev, Yu. V. Lukina, L. A. Sokolova, V. V. Yakusevich | ||
| "... . In case of insufficient antihypertensive effect dose of amlodipine was increased to 10 mg per day ..." | ||
| Vol 5, No 5 (2009) | EFFICACY AND SAFETY OF VASOACTIVE BETA-BLOCKERS IN ACUTE PHARMACOLOGICAL TEST IN HYPERTENSIVE PATIENTS OF DIFFERENT AGES | Abstract similar documents |
| O. V. Fedorishina, A. A. Dzizinsky, K. V. Protasov, V. A. Protasova, T. I. Kucherova, E. G. Zakharova, D. D. Baskhaeva, T. S. Sukhoroslova, O. V. Perkova | ||
| "... daily) therapy after wash-out period (3-10 days). Ambulatory blood pressure monitoring (ABPM ..." | ||
| Vol 7, No 5 (2011) | HOMOCYSTEINE-LOWERING THERAPY AND LONG-TERM PROGNOSIS AFTER ELECTIVE PERCUTANEOUS CORONARY INTERVENTION | Abstract similar documents |
| O. O. Shakhmatova, A. L. Komarov, A. N. Samko, T. I. Kotkina, D. V. Rebrikov, A. D. Deev, E. P. Panchenko | ||
| "... deficiency were not included. Patients were randomly assigned to receive combination of FA (0.6 mg/day), B12 ..." | ||
| Vol 10, No 1 (2014) | THE EFFICACY OF MELDONIUM IN REDUCTION OF CARDIAC ELECTRICAL INSTABILITY IN PATIENTS WITH ISCHEMIC STROKE | Abstract similar documents |
| A. A. Abdullaev, A. D. Magomedov, U. A. Islamova, Z. R. Umahanova | ||
| "... ;Grindex,Latvia;Pharmstandard,Russia), 1.0 g/day intravenously once daily, as a part of standard therapy ..." | ||
| Vol 1, No 2 (2005) | INFLUENCE OF MILDRONATE ON EFFICIENCY OF ANTIANGINAL THERAPY IN PATIENTS WITH STABLE BURDEN ANGINA | Abstract similar documents |
| N. P. Kutishenko, N. A. Dmitrieva, Y. V. Lukina, M. P. Kozireva, Y. E. Semyonova, A. D. Deev, S. Y. Martsevich | ||
| "... prescribed AAT without changes. After control period (10-14 days) was over, randomization of patients either ..." | ||
| Vol 8, No 1 (2012) | THE EFFICACY OF HIGH-DOSE SIMVASTATIN IN ACUTE PERIOD OF ISCHEMIC STROKE | Abstract similar documents |
| V. V. Yakusevich, A. Yu. Malygin, S. V. Lychenko, A. S. Petrochenko, A. V. Kabanov | ||
| "... stroke treated with simvastatin 40 mg/day in acute period of the disease. Materials and methods ..." | ||
| Vol 8, No 3 (2012) | EFFECT OF THE ETHYLMETHYLHYDROXYPYRIDINE SUCCINATE ON THE OXIDATIVE MODIFICATION OF SERUM PROTEINS IN PATIENTS WITH ISCHEMIC STROKE | Abstract similar documents |
| T. N. Khaybullin, E. Yu. Kravtsova, G. A. Martynova | ||
| "... in wave lengths of 356, 370, 430, 530 nm in 1, 3 and 15 days after IS in patients of the both groups ..." | ||
| Vol 11, No 6 (2015) | Left ventricular remodeling in patients with right ventricular myocardial infarction | Abstract similar documents |
| M. T. Beyshenkulov,, Z. M. Chazymova, A. S. Abylgazieva, K. R. Kaliev | ||
| "... and echocardiography were performed in all patients at admission, on days 3, 30 and 180 after MI. Results. Significant ..." | ||
| Vol 8, No 3 (2012) | COMPARATIVE EFFECTIVENESS PIPOFEZINE, TIANEPTINE AND CHLORPROTHIXENE IN PATIENTS WITH ATTENTION DEFICIT DISORDER , AND HYPERTENSION: AN OPEN NON-RANDOMIZED STUDY | Abstract similar documents |
| V. V. Glushchenko | ||
| "... into the study. Patients were split into three treatment groups: group 1 (n=19) received pipofezine 50 mg/day ..." | ||
| Vol 4, No 1 (2008) | EFFECT OF METOPROLOL ON COGNITIVE FUNCTION IN HYPERTENSIVE PATIENTS OF YOUNG TO MIDDLE AGE | Abstract similar documents |
| S. A. Smakotina, O. A. Trubnikova, O. L. Barbarash | ||
| "... day-time systolic and diastolic BP, maximum night-time diastolic BP, mean day-time systolic and night ..." | ||
| Vol 4, No 5 (2008) | EFFICACY AND SAFETY OF METOPROLOL SUCCINATE IN HIGH DOSES IN PATIENTS WITH STABLE COURSE OF ISCHEMIC HEART DISEASE | Abstract similar documents |
| S. N. Tolpygina, S. Y. Martsevich | ||
| "... Aim. To compare two initial doses (50 or 100mg/day) ofmetoprolol succinate in control released ..." | ||
| Vol 20, No 2 (2024) | Characteristics of the Russian population of patients with coronary artery disease or peripheral artery disease in the XATOA registry | Abstract similar documents |
| V. S. Arakelyan, A. D. Erlikh, N. Sh. Amirov, E. Dubar, K. Vogtlaender, S. Debus | ||
| "... inhibition therapy with rivaroxaban 2,5 mg twice a day and low-dose acetylsalicylic acid (ASA) daily were ..." | ||
| Vol 20, No 5 (2024) | Postmyocardial syndrome after myocardial infarction and percutaneous coronary intervention | Abstract similar documents |
| A. A. Klimenko, N. A. Demidova, V. V. Veselkin, T. A. Kirdyashkina, A. A. Chinova, Yu. A. Shandanovina | ||
| "... a day for 7 days, with a positive effect. Ten days after discharge, the patient noted an increase ..." | ||
| Vol 13, No 4 (2017) | HEALTHCARE RESOURCES UTILIZATION AND TEMPORARY DISABILITY IN POPULATION AGED 50-64 ACCORDING TO THE EPIDEMIOLOGICAL ESSE-RF STUDY | Abstract PDF (Eng) similar documents |
| A. V. Kontsevaya, Yu. A. Balanova, A. E. Imaeva, A. D. Deev, A. V. Kapustina, G. A. Muromtseva, S. E. Evstifeeva, S. A. Shalnova | ||
| "... (a number of days and cases), their mean number per one study participant, mean number of cases and days ..." | ||
| Vol 14, No 1 (2018) | ASSOCIATION OF RISK FACTORS FOR NON-COMMUNICABLE DISEASES WITH HEALTH CARE RESOURCES UTILIZATION AND TEMPORARY DISABILITY ACCORDING TO DATA OF POPULATION STUDY IN RUSSIAN FEDERATION | Abstract similar documents |
| E. I. Suvorova, S. A. Shalnova, A. V. Kontsevaya, A. D. Deev, A. V. Kapustina, Yu. A. Balanova | ||
| "... (including duration of in-hospital treatment and number of cases), ambulance calls and TD (a number of days ..." | ||
| 1 - 100 of 271 Items | 1 2 3 > >> | |
Search tips:
- Search terms are case-insensitive
- Common words are ignored
- By default articles containing any term in the query are returned (i.e., OR is implied)
- Make sure that a word exists in an article by prefixing it with +; e.g., +journal +access scholarly academic
- Combine multiple words with AND to find articles containing all terms; e.g., education AND research
- Exclude a word by prefixing it with - or NOT; e.g., online -politics or online NOT politics
- Search for an exact phrase by putting it in quotes; e.g., "open access publishing". Hint: Quoting Chinese or Japanese words will help you to find exact word matches in mixed-language fields, e.g. "中国".
- Use parentheses to create more complex queries; e.g., archive ((journal AND conference) NOT theses)
